RT Journal Article
SR Electronic
T1 Deep learning of SARS-CoV-2 outbreak phylodynamics with contact tracing data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.10.24308687
DO 10.1101/2024.06.10.24308687
A1 Xie, Ruopeng
A1 Adam, Dillon C.
A1 Hu, Shu
A1 Cowling, Benjamin J.
A1 Gascuel, Olivier
A1 Zhukova, Anna
A1 Dhanasekaran, Vijaykrishna
YR 2024
UL http://medrxiv.org/content/early/2024/06/11/2024.06.10.24308687.abstract
AB Deep learning has emerged as a powerful tool for phylodynamic analysis, addressing common computational limitations affecting existing methods. However, notable disparities exist between simulated phylogenetic trees used for training existing deep learning models and those derived from real-world sequence data, necessitating a thorough examination of their practicality. We conducted a comprehensive evaluation of model performance by assessing an existing deep learning inference tool for phylodynamics, PhyloDeep, against realistic phylogenetic trees characterized from SARS-CoV-2. Our study reveals the poor predictive accuracy of PhyloDeep models trained on simulated trees when applied to realistic data. Conversely, models trained on realistic trees demonstrate improved predictions, despite not being infallible, especially in scenarios where superspreading dynamics are challenging to capture accurately. Consequently, we find markedly improved performance through the integration of minimal contact tracing data. Applying this approach to a sample of SARS-CoV-2 sequences partially matched to contact tracing from Hong Kong yields informative estimates of SARS-CoV-2 superspreading potential beyond the scope of contact tracing data alone. Our findings demonstrate the potential for enhancing deep learning phylodynamic models processing low resolution trees through complementary data integration, ultimately increasing the precision of epidemiological predictions crucial for public health decision making and outbreak control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institutes of Health contract number 75N93021C00016 (VD) Research Grants Council of the Hong Kong SAR, China (Project No. [T11-705/21-N]) (VD) The Collaborative Research Scheme (Project No. C7123-20G) of the Research Grants Council of the Hong Kong Special Administrative Region, China (BC, DA) Health and Medical Research Fund Seed Grant Scheme (Project No. 22211192) of the Hong Kong SAR (DA) HKU-Pasteur Research Pole Fellowship 2023 (S-AC23005-01) (RX) PaRis AI Research InstitutE (PRAIRIE; ANR-19-P3IA-0001) (OG) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript